TY - JOUR AU - Scher, H I; Jia, X; Chi, K; de Wit, R; Berry, W R; Albers, P; Henick, B; Waterhouse, D; Ruether, D J; Rosen, P J; Meluch, A A; Nordquist, L T; Venner, P M; Heidenreich, A; Chu, L; Heller, G TI - Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer JO - J Clin Oncol VL - 29 PY - 2011 DO - 10.1200/JCO.2010.32.8815 L3 - PubMed-ID: 21483004 SP - 2191 EP - 2198 ER -